S. Martin Lluesma

Discipline

Economies et finances (1)

Type de document

Articles (4) Recensions (3)

Co-auteur

L.E. Kandalaft

A. Harari

K. Zaman

A. Wolfer

M.C. Vozenin

P.G. Tsoutsou

B.J. Stevenson

C. Sempoux

A. Sarivalasis

L. Rossier

P Mathevet

L. Kandalaft

E.M. Iancu

M. Graciotti

P.O. Gannon

U. Dafni

G. Coukos

C.L. Chiang

L. Cagnon

C. Boudousquie

K. Balint

Date

Source

Serveur académique Lausannois (4)

Mot-clé

cancer (4) Cancer (4) Immunotherapy (4) Cancer (4) Immunotherapy (4) Vaccines (3) Vaccination (3) Vaccination (3) Development (2) Surgery (2) Treatment (2) Chemotherapy (2) Will (2) Theater (2) Surgery (2) Poor (2) Lymphocytes (2) Drama (2) Chemotherapy (2) Cancer--Patients (2) Acting (2) Cancer vaccines (2) Will (2) roman (2) véhicule (1) toxicité (1) norme (1) sécurité (1) enregistrement (1) association (1)

Documents écrit par S. Martin Lluesma (4) | parle de S. Martin Lluesma (0)

A Phase I/II trial comparing autologous dendritic cell vaccine pulsed either with personalized peptides (PEP-DC) or with tumor lysate (OC-DC) in patients with advanced high-grade ovarian serous carcinoma.

A. Sarivalasis et al. (26 nov. 2019)

Does the Immunocompetent Status of Cancer Patients Have an Impact on Therapeutic DC Vaccination Strategies?

S. Martin Lluesma et al. (23 nov. 2018)

Emerging Opportunities of Radiotherapy Combined With Immunotherapy in the Era of Breast Cancer Heterogeneity.

P.G. Tsoutsou et al. (2018)

Cancer Vaccines in Ovarian Cancer: How Can We Improve?

S. Martin Lluesma et al. (3 mai 2016)